Divi's Laboratories Limited

SBI Mutual Fund decreased its stake in Divi's Laboratories from 4.21% to 3.90%, selling 836,907 shares worth approximately ₹71.1 Cr at ₹8496.00 per share. SBI Healthcare Opportunities Fund, managed by SBI Mutual Fund, still holds 7.46% of its assets in Divi's Laboratories as of July 31, 2026.

A leading manufacturer and exporter of active pharmaceutical ingredients, intermediates, and nutraceutical ingredients serving global pharmaceutical and healthcare markets. Incorporated in 1990, the company operates across multiple therapeutic segments with vertically integrated manufacturing infrastructure. It distinguishes itself through expertise in complex chemistry, stringent quality standards, and a diversified product portfolio catering to customers worldwide.

India's largest AMC by total AUM, managing over Rs 11 lakh crore across equity, debt and hybrid schemes. Backed by State Bank of India, the country's largest bank, which gives it unmatched retail reach across every Indian state. With over 70 schemes and 50 million folios, SBI MF's positioning moves are tracked as a proxy for domestic institutional flows.